Investigators involved in clinical trials will tell you how important single sign-on would be to them. Speaking with investigational sites involved in multiple trials, they explain how operating multiple technology solutions in each study, and running multiple studies, means they need to maintain many different username and password combinations. This becomes impossible to manage without writing them down somewhere, which raises questions about the practicality of this approach in maintaining security and access control. Single sign-on is something the industry has viewed as a golden nugget and technology vendors are rising to the challenge. This article considers a step beyond simply enabling user access, to establishing a shared common user identity across applications, and importantly the potential this has to create a new and optimized way to present technology…
Bill Byrom, Senior Director of Product Strategy, Perceptive Informatics. Perceptive Informatics is an eClinical solutions provider that helps customers accelerate the drug development process through innovation. For more information, visit perceptive.com.